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Brucellosis studies 
• Brucellosis control (mass 
vaccination) 
– Mongolia, Kirghizstan 
• Brucellosis surveillance system 
(abattoir) 
– Senegal 
– Kirghizstan 
• Joint human-animal 
seroprevalence 
– Sahelian zone: Mali, Senegal 
– Humid zone: Togo, Côte d’Ivoire 
• Brucella strain mapping in West 
Africa 
 
Evidence in value added for 
decision 
People to  
relate 
Ecosystem 
Human Animal 
Added value creation 
Tackling health 
complexity 
with discipline 
& Knowledge 
fragmentation 
1/29/2013 5 Brucellosis in Africa 
Transformation of production 
system 
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Transformation of livestock 
production system 
• Herding 
• Marketing 
• Consumption 
patterns 
• Legal aspects 
• Genetic 
improvement
… 
Context and institution matter 
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Urbanisation of brucellosis in 
Africa 
• In Africa, livestock is a faster way to get the 
population out of poverty (Alive, 2012) 
• Livestock is also a contreverse as far as green gas 
emission and soils/ pasture degradation are 
concerned (Livestock long shadow) 
• Demand in protein is increasing due population 
growth and income generation.. 
• Livestock while contributing to food security and 
livelihoods of the population can spill out diseases 
(majority of zoonoses are from animal origin). 
• The control is possible in the reservoir but there is 
imbalance resource allocation…unknown true 
burden. 
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Socio-economics of 
brucellosis 
What is the burden? 
Public health of economic 
perspective 
1/29/2013 Brucellosis in Africa 10 
Is brucellosis a priority? 
Is there evidence for intervention 
decision ? 
 • Contact network and interfaces 
• Estimates and data quality 
• Targeting intervention with 
epidemiological parameters (age 
groups, species, zones, …) 
• Cost of the disease, cost-effectiveness 
• Benefit sharing 
• Incentives (services) for actors 
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Intervention in Mongolia 
• Test & slaughter  1960; 
Vaccination 1970/80 
• 1990: Privatisation stop of 
surveillance 
• 1996-98 WHO planned vaccination 
campaign 
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Human brucellosis
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Objectives of economics 
1. Estimate the damage of Brucellosis 
2. Cost effectiveness analysis to human 
population 
3. Estimate economic gain from all flock 
vaccination 
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Methods and data collection 
Methodology 
• patient based household survey 
• Inventory of existing data  
• Delphi study on human Brucellosis 
• Delphi study on animal Brucellosis 
• Theoretical deterministic model of animal to 
human  Brucellosis transmission in Vensim® 
• development of @Risk ® -LDPS(FAO)-EXCEL 
® spreadsheet (Ecozoo) 
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Selection of alternatives 
• Current test an slaughter practice 
(non compulsory culling of positive 
animals, no state compensation) 
• Whole herd vaccination program 
developed (scenarios of 30-80% 
effectiveness) 
• 2 years all animals then only young 
ones: Rev1, S19 
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Modelling: Epidemiologic and Economical 
considerations 
• Animal to animal transmission dynamics 
• Simulation of interventions 
• Animal to human transmission 
• Need for underlying transmission model 
• Data quality 
– survey and reported data 
– method standardisation 
• Linkage of disease prevalence to  
– livestock productivity 
– health cost 
– linkage to prices 
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Link of disease data to livestock 
production and human health cost 
• Human Health  
 
– Number of cases = Population * Exposure constant    
                    * Cumulative Incidence 
• Livestock productivity (only fertility and milk 
production) 
– Baseline Fertility: annual number of offspring per breeding 
female 
– Fertility= baseline fertility   * (1 - (Beta-Pert (10%; 15%; 
50%)  * Prevalence )) 
 
 
Brucellosis in Africa 
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ECOZOO V 1.0: outline* 
*disease transmission simulation is not included 
Tables
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Summary of human health cost 
Inpatient costs
Outpatient costs
Out of pocket expenses for health care
Informal Treatment costs
Loss of income
Coping costs
Brucellosis in Africa 
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Outcomes of Household study 
Estimation of parameters 
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Linking disease prevalence and livestock productivity 
• What is the loss of livestock production from brucellosis 
• Main effect on fertility 
• Baseline fertility 
– Cattle 0.7 calves / cow / year; 1000 l milk / cow / year 
– Small ruminants 1.2 lambs / ewe / year 
• Livestock productivity Baseline Fertility: annual 
number of offspring per breeding female 
– Fertility= baseline fertility                  
* (1 – (0.15)*Prevalence ) 
– Cattle 0.695, Small ruminants 1.195 
– Milkproduction = baseline * (1-0.15)*Prevalence) 
– Cattle 996 l milk / cow per year 
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Synoptic view of benefits and costs of animal 
brucellosis mass vaccination in Mongolia 
Brucellosis in Africa 
Other socio-economic factors 
• Benefit & benefit distribution 
– Society, private, public health, agric sector 
 
• Costing interventions 
– Diagnostic, surveillance, control (laboratory, 
reagent, sampling, vaccine production) 
–   
• Research area 
– Fertility, productivity, household economics, 
DALY, strain for vaccine,modelling transmission 
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Other case studies 
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Surveillance in Kirghystan 
• Representative animal and human 
brucellosis prevalence and incidence 
– The study aimed to establish the 
brucellosis sero-prevalence in livestock 
and the incidence of newly recorded 
human cases representative for 
Kyrgyzstan. 
– The sampling frame is a multistage cluster 
sampling by levels of Oblast, Rayon, 
village and households 
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Reducing surveillance cost 
• Dialog and intersectoral approach 
• Capacity building (eg. 
quantitative epidemiology) 
• Lab analysis (mutualisation of 
resources) 
• Cost of the representative 
prevalence study ~60‘000 Dollars 
–   method could reduce the cost 
of the national surveillance 
program 
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Joint sampling 
Prise de sang par l’infirmier 
Prise de sang du bétail 
Cross-sectional study Togo 
Villages randomly 
selected 
 683 peoples, 596 bovines, 686 small ruminants in 25 villages (juin-juillet 2011) 
 464 transhumants from Burkina Faso (février-mars 2012) 
TOGO   
 Abortion risque for Brucellosis: OR 3.8 (95%IC: 
1.2-12.1) (previous year adjusted for age) 
1/29/2013 29 Brucellosis in Africa 
Actors capacity building 
New generation of researchers, 
practitionners and decision-
makers 
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Afrique One
Multi pathogens „zoonoses & other diseases“ 
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Emerging Zoonoses 
„Afrique anglophone & francophone“ 
Scale 
Afrique One set up 
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New research perspective 
Socio-economics 
Public health 
Risk Assessment 
Value Chain 
Reversing 
the Public 
Health and 
economic 
view on 
brucellosis 
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Conclusion 
• Situation better known in animal than in human 
• Test and slaughter policy is very not likely applicable 
(compensation, logistics…) 
• Option of mass vaccination in semi-intensive and 
intensive production system 
– Reduce transmissio at a level te prevent human infection 
– Cutting transmission by pasteurisation, marketing system 
• Combining brucella vaccine with other dead 
vaccines…. 
• Evidence based advocacy and policy influencing 
• Methodological tools on cost-benefit analysis of 
disease control based on brucellosis case study 
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